Healthcare provider profile · identity verified

Kara Erickson, PAC

Physician Assistant · MILES CITY, MT · NPI 1336233055

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	645	134
Gabapentin	Gabapentin	422	76
Atorvastatin Calcium	Atorvastatin Calcium	403	101
Pantoprazole Sodium	Pantoprazole Sodium	376	78
Omeprazole	Omeprazole	319	74
Losartan Potassium	Losartan Potassium	304	89
Furosemide	Furosemide	293	67
Potassium Chloride	Potassium Chloride	293	66
Amlodipine Besylate	Amlodipine Besylate	263	64
Lisinopril	Lisinopril	231	55
Metoprolol Succinate	Metoprolol Succinate	226	54
Tramadol Hcl	Tramadol Hcl	218	43
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	210	37
Escitalopram Oxalate	Escitalopram Oxalate	188	43
Montelukast Sodium	Montelukast Sodium	172	43
Celecoxib	Celecoxib	152	37
Jardiance	Empagliflozin	152	24
Tamsulosin Hcl	Tamsulosin Hcl	139	39
Sertraline Hcl	Sertraline Hcl	138	26
Eliquis	Apixaban	131	20
Trazodone Hcl	Trazodone Hcl	125	28
Carvedilol	Carvedilol	124	29
Baclofen	Baclofen	122	22
Synthroid	Levothyroxine Sodium	122	26
Metformin Hcl Er	Metformin Hcl	121	28
Simvastatin	Simvastatin	118	30
Tizanidine Hcl	Tizanidine Hcl	116	33
Duloxetine Hcl	Duloxetine Hcl	115	22
Januvia	Sitagliptin Phosphate	114	17
Metformin Hcl	Metformin Hcl	107	25
Ondansetron Odt	Ondansetron	104	28
Albuterol Sulfate Hfa	Albuterol Sulfate	103	44
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	99	21
Quetiapine Fumarate	Quetiapine Fumarate	99	15
Meloxicam	Meloxicam	97	26
Buspirone Hcl	Buspirone Hcl	95	21
Oxycodone Hcl	Oxycodone Hcl	95	11
Metoprolol Tartrate	Metoprolol Tartrate	90	18
Solifenacin Succinate	Solifenacin Succinate	88	14
Oxybutynin Chloride	Oxybutynin Chloride	87	15
Clopidogrel	Clopidogrel Bisulfate	85	14
Hydrochlorothiazide	Hydrochlorothiazide	84	24
Spironolactone	Spironolactone	79	16
Rosuvastatin Calcium	Rosuvastatin Calcium	78	17
Hydroxyzine Hcl	Hydroxyzine Hcl	76	suppressed
Fluticasone Propionate	Fluticasone Propionate	75	23
Prednisone	Prednisone	75	32
Donepezil Hcl	Donepezil Hcl	73	11
Ozempic	Semaglutide	73	13
Finasteride	Finasteride	72	19
Alendronate Sodium	Alendronate Sodium	71	11
Lorazepam	Lorazepam	71	19
Alprazolam	Alprazolam	68	11
Bupropion Xl	Bupropion Hcl	66	21
Clonazepam	Clonazepam	66	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	66	12
Triamcinolone Acetonide	Triamcinolone Acetonide	65	32
Allopurinol	Allopurinol	64	15
Hydralazine Hcl	Hydralazine Hcl	61	13
Methocarbamol	Methocarbamol	61	suppressed
Nabumetone	Nabumetone	61	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	61	suppressed
Sucralfate	Sucralfate	61	11
Citalopram Hbr	Citalopram Hydrobromide	60	16
Estradiol	Estradiol	57	16
Zolpidem Tartrate	Zolpidem Tartrate	57	11
Myrbetriq	Mirabegron	52	15
Propranolol Hcl	Propranolol Hcl	52	suppressed
Valsartan	Valsartan	52	11
Methylprednisolone	Methylprednisolone	49	34
Ropinirole Hcl	Ropinirole Hcl	49	suppressed
Xarelto	Rivaroxaban	49	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	47	suppressed
Ventolin Hfa	Albuterol Sulfate	46	17
Mirtazapine	Mirtazapine	45	11
Amitriptyline Hcl	Amitriptyline Hcl	44	suppressed
Cefdinir	Cefdinir	42	30
Pravastatin Sodium	Pravastatin Sodium	40	11
Topiramate	Topiramate	40	suppressed
Cephalexin	Cephalexin	39	20
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	12
Warfarin Sodium	Warfarin Sodium	39	suppressed
Nystatin	Nystatin	38	24
Trulicity	Dulaglutide	37	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	36	suppressed
Benazepril Hcl	Benazepril Hcl	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	34	22
Valacyclovir	Valacyclovir Hcl	33	suppressed
Fluconazole	Fluconazole	32	20
Olmesartan Medoxomil	Olmesartan Medoxomil	32	suppressed
Torsemide	Torsemide	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Mounjaro	Tirzepatide	30	suppressed
Mupirocin	Mupirocin	30	21
Clonidine Hcl	Clonidine Hcl	26	suppressed
Diclofenac Sodium-Misoprostol	Diclofenac Sodium/Misoprostol	26	suppressed
Divalproex Sodium Er	Divalproex Sodium	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	19
Olanzapine	Olanzapine	25	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Linzess	Linaclotide	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Spiriva Respimat	Tiotropium Bromide	24	suppressed
Bumetanide	Bumetanide	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Primidone	Primidone	23	suppressed
Tresiba Flextouch U-100	Insulin Degludec	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	19	suppressed
Arnuity Ellipta	Fluticasone Furoate	18	suppressed
Carbamazepine	Carbamazepine	18	suppressed
Digoxin	Digoxin	18	suppressed
Spiriva Handihaler	Tiotropium Bromide	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	12
Azithromycin	Azithromycin	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Dexamethasone	Dexamethasone	16	11
Hydroxyzine Pamoate	Hydroxyzine Pamoate	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Risedronate Sodium	Risedronate Sodium	15	suppressed
Creon	Lipase/Protease/Amylase	14	suppressed
Metolazone	Metolazone	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Famotidine	Famotidine	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Minoxidil	Minoxidil	13	suppressed
Potassium Citrate Er	Potassium Citrate	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Diazepam	Diazepam	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	12	suppressed
Levoxyl	Levothyroxine Sodium	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Mesalamine Er	Mesalamine	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Valproic Acid	Valproic Acid	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	11	suppressed
Dotti	Estradiol	11	suppressed
Famciclovir	Famciclovir	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Prevacid	Lansoprazole	11	suppressed
Probenecid-Colchicine	Probenecid/Colchicine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error